- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Dr Shamsheer Vayalil to setup a Super-speciality hospital in London
A super-speciality hospital to be set up in London by a UAE-based Indian,Dr Shamsheer Vayalil
Being developed by health giant VPS Healthcare group, the new hospital will be focused on cancer treatment becoming the first hospital in UK to offer Proton Beam Therapy
VPS Healthcare group, a leading healthcare provider in India and the Middle East, is on a special mission led by a UAE based Indian doctor. The healthcare group has recently announced their plans to launch a super speciality hospital in London, with a focus on providing cancer treatment. Set to be operational by 2017, the new infrastructure will provide jobs to 2000 people in the city.
The new private hospital is also the first of its kind to offer Proton Beam Therapy - a type of radiotherapy that uses sub-atomic particles to attack cancer cells with less damage to surrounding tissues than conventional radiotherapy. Proton beam therapy is currently generally unavailable through the NHS (National Health Service) in the UK, though a small group of patients have availed the treatment outside UK, as per the medical recommendations of their care team.
As reported by PTI
Dr Shamsheer Vayali, founder and managing director of the VPS Healthcare Group, told reporters today that "the new centre will be created within the historic grade II listed Royal Masonic Hospital in Hammersmith which closed in 2006."
The facility will open in 2017 with a bed capacity of 150 and will be supported by around 2,000 staff in jobs ranging from administration, support and service roles to leading specialist healthcare professionals.
The new 'super-speciality' cancer treatment will be available at the hospital through the NHS from 2018.
"VPS Healthcare has been encouraged by the UK Government's ongoing policy to support health and pharmaceutical companies, and we believe that our investment in this dynamic sector will not only ensure that we play a key role in supporting this initiative, but will also help to grow and develop the next generation of medical breakthroughs," said 38-year-old Vayali, the youngest recipient of the Pravasi Bharatiya Samman Award in 2014.
He said that the new London hospital represented a major investment for VPS Healthcare and is its first entry into the UK market.
VPS Healthcare is recognised as a Global Growth Company by the World Economic Forum and is also a member of the MENA Regional Partnership Community of the WEF.
The company is holder of the Guinness World Record for largest Simultaneous Self-Examination for Breast Cancer.
Welcoming the investment, the Mayor of London Boris Johnson said: "This is tremendous vote of confidence in London's thriving life sciences sector as well as the skills and talent of our amazing healthcare professionals.
"London is a world leader in medical sciences and through MedCity we are working to generate the jobs and growth that will propel this important sector to even greater things."
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story